Clinical Trials Collective Supply Chain 
Cannabis Law Report
AUGUST 3, 2021
Testing under the Contract will commence in early August 2021, and all sample collection sites will be fully operational before the start of the academic year on August 25. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.
Cannabis Law Report
SEPTEMBER 2, 2021
The Contract contains no minimum testing requirement; it stipulates a fixed monthly fee for sample collection site services and a separate fixed fee per individual COVID-19 test. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 28, 2021
We look forward to providing continued updates on our intellectual property, research, clinical, regulatory and manufacturing activities for PD-001; our novel oral formulation of cepharanthine, with the aim of working towards a first-in-human, proof-of-concept clinical trial under an FDA IND approval.” ” Next Steps.
Cannabis Law Report
SEPTEMBER 14, 2021
Radicle Science disrupts the traditional clinical trial model by combining the reach of a market research company, the scientific rigor of a research university, and the agility of a tech company. About Radicle Science. Headquartered in Roxboro, N.C.,
Cannabis Law Report
OCTOBER 12, 2021
Mary Hartnett, Director of Medical Services at Sarah Lawrence College, stated, “safeCircle was our choice given the convenience of its on-site sample collection process, access to high-sensitivity RT-PCR-based testing with rapid turnaround times, ability to scale with our needs, and capacity to ease our administrative burdens.
Cannabis Law Report
SEPTEMBER 3, 2019
Kate Larson, Senior Regulatory Affairs Advisor , is an expert in international pharmaceutical and nutrition industries’ regulatory compliance and registration for innovator product development and manufacturing, including quality testing, clinical trials, safety, toxicity, and import/export processes. Global Supply Chain Platform.
Cannabis Law Report
NOVEMBER 7, 2019
chemovars) in house to ensure strict guidelines are followed to supply a consistent and clean medicinal product at low costs. With a strong focus on research and development ranging from agronomic research through to clinical trials Cannatrek has an extensive R&D portfolio from Seed to Patient.
Expert insights. Personalized for you.
Let's personalize your content